Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich, Gene Oracle Sign Supply Agreement

NEW YORK (GenomeWeb News) – Sigma-Aldrich will supply oligonucleotides to the synthetic biology company Gene Oracle, and the companies will partner in co-marketing efforts, Sigma-Aldrich said today.

Customers will use the Sigma-Aldrich oligonucleotides to create synthetic genes in tandem with Gene Oracle's GeneIOS gene sequencing software. The process will allow researchers to generate custom synthetic genes within a single day, Sigma-Aldrich said.

The agreement makes Sigma-Aldrich Gene Oracle's exclusive oligonucleotide supplier.

Financial terms of the agreement were not released.

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.